UBS Maintains Neutral on Corteva, Lowers Price Target to $10
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and lowers the price target from $15 to $10.